Acitazanolast
Drug profile
Also known as: acitazanolast hydrate, WP-871, zepelin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Acitazanolast is a drug catalogued in DrugCentral. Recorded indications include Allergic conjunctivitis.
- Indications: Allergic conjunctivitis.
- Molecular formula: C9H7N5O3; molecular weight 233.19 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Allergic conjunctivitis
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Acitazanolast is on its molecule page.
| Molecular formula | C9H7N5O3 |
|---|---|
| Molecular weight | 233.19 g/mol |
| CAS number | 114607-46-4 |
| InChIKey | VWQZJJZGISNFOE-UHFFFAOYSA-N |
| PubChem CID | 2006 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Acitazanolast used for?
DrugCentral lists the following indications for Acitazanolast: Allergic conjunctivitis.
What is the chemical formula of Acitazanolast?
Acitazanolast has the molecular formula C9H7N5O3 and a molecular weight of 233.19 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 77 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2104654 — compound record and bioactivity
- PubChem CID 2006 — chemical identifiers
- FDA UNII 99Y8VJ356G — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.